Cas no 81446-29-9 ((-)-pinoresinol)

(-)-Pinoresinol is a naturally occurring lignan found in various plant species, including Forsythia suspensa and sesame seeds. It exhibits notable biological activities, such as antioxidant, anti-inflammatory, and potential anticancer properties, making it a compound of interest in pharmaceutical and nutraceutical research. Its chiral structure and stereospecificity contribute to its selective interactions with biological targets. (-)-Pinoresinol is also a precursor in the biosynthesis of other lignans, underscoring its significance in synthetic and medicinal chemistry. High-purity (-)-pinoresinol is available for research applications, ensuring reproducibility in studies investigating its mechanisms and therapeutic potential. Its stability and well-characterized properties facilitate its use in analytical and biochemical assays.
(-)-pinoresinol structure
(-)-pinoresinol structure
Product Name:(-)-pinoresinol
CAS No:81446-29-9
MF:C20H22O6
MW:358.385086536407
CID:2078613
PubChem ID:11168362
Update Time:2025-05-21

(-)-pinoresinol Chemical and Physical Properties

Names and Identifiers

    • (-)-pinoresinol
    • (+)-
    • (+-)-1c,4c-Bis-(4-hydroxy-3-methoxy-phenyl)-(3ar,6ac)-tetrahydro-furo[3,4-c]furan
    • (+)-Pinoresinol
    • (+/-)-pinoresinol
    • (7S,7'S,8R,8'R)-3,3'-dimethoxy-7,9':7',9-diepoxylignane-4,4'-diol
    • 1,4-Bis-(4-hydroxy-3-methoxy-phenyl)-tetrahydro-furo[3,4-c]furan
    • 2,2'-dimethoxy-4,4'-(tetrahydro-furo[3,4-c]furan-1,4-diyl)-bis-phenol
    • 2,6-bis-(3-methoxy-4-hydroxy phenyl)-cis-3,7-dioxabicyclo[3.3.0]octane
    • 2,6-di(4-hydroxy-3-methoxyphenyl)-3,7-dioxabicyclo[3.3.0]octane
    • pinoresinol
    • (+)-syringaresinol
    • pinoresinol monomethyl ether
    • 1H,3H-Furo[3,4-c]furan, phenol deriv. (ZCI)
    • 4,4′-[(1R,3aS,4R,6aS)-Tetrahydro-1H,3H-furo[3,4-c]furan-1,4-diyl]bis[2-methoxyphenol] (ACI)
    • Phenol, 4,4′-(tetrahydro-1H,3H-furo[3,4-c]furan-1,4-diyl)bis[2-methoxy-, [1R-(1α,3aα,4α,6aα)]- (ZCI)
    • Q27155117
    • 41607-20-9
    • (-)-pinoresinol glucoside
    • CHEMBL573336
    • C17529
    • AKOS040762633
    • FS-6845
    • CHEBI:81162
    • D85072
    • Epipinoresinol-4-O-beta-D-glucoside
    • (2S,3R,4S,5S,6R)-2-[4-[(3R,3aS,6R,6aS)-3-(4-hydroxy-3-methoxyphenyl)-1,3,3a,4,6,6a-hexahydrofuro[3,4-c]furan-6-yl]-2-methoxyphenoxy]-6-(hydroxymethyl)oxane-3,4,5-triol
    • HY-N0946
    • CS-0016079
    • (-)-Pinoresinol 4-O-glucoside
    • Q27135716
    • SCHEMBL15481159
    • (7beta,7'beta,8beta,8'beta)-3,3'-dimethoxy-7,9':7',9-diepoxylignane-4,4'-diol
    • GLXC-14834
    • CHEMBL267963
    • BDBM50208826
    • C20455
    • 4-[(3R,3aS,6R,6aS)-6-(3-methoxy-4-oxidanyl-phenyl)-1,3,3a,4,6,6a-hexahydrofuro[3,4-c]furan-3-yl]-2-methoxy-phenol
    • AKOS040760637
    • 81446-29-9
    • 4-[(3R,3aS,6R,6aS)-6-(4-hydroxy-3-methoxyphenyl)-1,3,3a,4,6,6a-hexahydrofuro[3,4-c]furan-3-yl]-2-methoxyphenol
    • FS-7642
    • 4-[(1S,3aR,4S,6aR)-4-(4-hydroxy-3-methoxyphenyl)tetrahydro-1H,3H-furo[3,4-c]furan-1-yl]-2-methoxyphenol
    • 4,4'-(1R,3aS,4R,6aS)-tetrahydro-1H,3H-furo[3,4-c]furan-1,4-diylbis(2-methoxyphenol)
    • (?)-Pinoresinol
    • CHEBI:67245
    • 4,4'-(1R,3aS,4R,6aS)-tetrahydro-1H,3H-furo(3,4-c)furan-1,4-diylbis(2-methoxyphenol)
    • DA-59411
    • 4-((3R,3aS,6R,6aS)-6-(4-hydroxy-3-methoxyphenyl)-1,3,3a,4,6,6a-hexahydrofuro(3,4-c)furan-3-yl)-2-methoxyphenol
    • Inchi: 1S/C20H22O6/c1-23-17-7-11(3-5-15(17)21)19-13-9-26-20(14(13)10-25-19)12-4-6-16(22)18(8-12)24-2/h3-8,13-14,19-22H,9-10H2,1-2H3/t13-,14-,19+,20+/m1/s1
    • InChI Key: HGXBRUKMWQGOIE-NSMLZSOPSA-N
    • SMILES: O(C1C(O)=CC=C([C@@H]2OC[C@H]3[C@H](C4C=CC(O)=C(OC)C=4)OC[C@@H]23)C=1)C

Computed Properties

  • Exact Mass: 358.14200
  • Monoisotopic Mass: 520.19446183g/mol
  • Isotope Atom Count: 0
  • Hydrogen Bond Donor Count: 2
  • Hydrogen Bond Acceptor Count: 6
  • Heavy Atom Count: 26
  • Rotatable Bond Count: 4
  • Complexity: 741
  • Covalently-Bonded Unit Count: 1
  • Defined Atom Stereocenter Count: 9
  • Undefined Atom Stereocenter Count : 0
  • Defined Bond Stereocenter Count: 0
  • Undefined Bond Stereocenter Count: 0
  • XLogP3: 0.5
  • Topological Polar Surface Area: 157?2

Experimental Properties

  • Color/Form: Powder
  • Density: 1.287±0.06 g/cm3 (20 oC 760 Torr),
  • Melting Point: 119-120 oC
  • Boiling Point: 556.5±50.0 °C at 760 mmHg
  • Flash Point: 290.4±30.1 °C
  • Solubility: Very slightly soluble (0.14 g/l) (25 o C),
  • PSA: 77.38000
  • LogP: 3.19020
  • Vapor Pressure: 0.0±1.6 mmHg at 25°C

(-)-pinoresinol Security Information

(-)-pinoresinol Pricemore >>

Related Categories No. Product Name Cas No. Purity Specification Price update time Inquiry
ChemFaces
CFN92287-5mg
(-)-Pinoresinol
81446-29-9 >=98%
5mg
$268 2021-07-22
SHANG HAI JI ZHI SHENG HUA Technology Co., Ltd.
P27990-5mg
Pinoresinol
81446-29-9
5mg
¥2400.0 2021-09-08
SHANG HAI TAO SHU Biotechnology Co., Ltd.
TN2079-5 mg
(-)-Pinoresinol
81446-29-9
5mg
¥2814.00 2022-04-26
SHANG HAI TAO SHU Biotechnology Co., Ltd.
TN2079-5mg
(-)-Pinoresinol
81446-29-9 99.78%
5mg
¥ 3980 2023-09-08
SHANG HAI TAO SHU Biotechnology Co., Ltd.
TN2079-10mg
(-)-Pinoresinol
81446-29-9 99.78%
10mg
¥ 5970 2023-09-08
TargetMol Chemicals
TN2079-5mg
(-)-Pinoresinol
81446-29-9 99.78%
5mg
¥ 2380 2024-07-20
TargetMol Chemicals
TN2079-10mg
(-)-Pinoresinol
81446-29-9 99.78%
10mg
¥ 3400 2024-07-20
ChemFaces
CFN92287-5mg
(-)-Pinoresinol
81446-29-9 >=98%
5mg
$268 2023-09-19
TargetMol Chemicals
TN2079-5 mg
(-)-Pinoresinol
81446-29-9 99.78%
5mg
¥ 3,980 2023-07-11
A2B Chem LLC
AH49923-500mg
(-)-Pinoresinol
81446-29-9 98% by HPLC
500mg
$16969.00 2024-04-19

(-)-pinoresinol Production Method

Production Method 1

Reaction Conditions
1.1 Reagents: Oxygen Catalysts: Laccase Solvents: Ethanol ,  Water ;  pH 5, rt; 1 h, rt
1.2 Reagents: Hydrochloric acid Solvents: Water ;  acidified
Reference
An enantiocomplementary dirigent protein for the enantioselective laccase-catalyzed oxidative coupling of phenols
Pickel, Benjamin; et al, Angewandte Chemie, 2010, 49(1), 202-204

Production Method 2

Reaction Conditions
1.1 Reagents: Glucose ,  Sucrose ,  Potassium chloride ,  Sulfuric acid magnesium salt (1:1) ,  Ferrous sulfate ,  Dipotassium phosphate Solvents: Dimethyl sulfoxide ,  Water ;  72 h, 25 °C
Reference
Enantioselective accumulation of (-)-pinoresinol through O-demethylation of (±)-eudesmin by Aspergillus niger
Kasahara, Hiroyuki; et al, Phytochemistry, 1997, 44(8), 1479-1482

Production Method 3

Reaction Conditions
1.1 24 h, rt
2.1 Reagents: Glucose ,  Sucrose ,  Potassium chloride ,  Sulfuric acid magnesium salt (1:1) ,  Ferrous sulfate ,  Dipotassium phosphate Solvents: Dimethyl sulfoxide ,  Water ;  72 h, 25 °C
Reference
Enantioselective accumulation of (-)-pinoresinol through O-demethylation of (±)-eudesmin by Aspergillus niger
Kasahara, Hiroyuki; et al, Phytochemistry, 1997, 44(8), 1479-1482

Production Method 4

Reaction Conditions
1.1 Reagents: NADPH ,  Hydrogen peroxide Solvents: Water ;  1 h, pH 7, 30 °C
Reference
Enantioselective lignan synthesis by cell-free extracts of Forsythia koreana
Umezawa, Toshiaki; et al, Bioscience, 1994, 58(2), 230-4

Production Method 5

Reaction Conditions
1.1 Reagents: Glucose ,  Sucrose ,  Potassium chloride ,  Sulfuric acid magnesium salt (1:1) ,  Ferrous sulfate ,  Dipotassium phosphate Solvents: Dimethyl sulfoxide ,  Water ;  72 h, 25 °C
Reference
Enantioselective accumulation of (-)-pinoresinol through O-demethylation of (±)-eudesmin by Aspergillus niger
Kasahara, Hiroyuki; et al, Phytochemistry, 1997, 44(8), 1479-1482

Production Method 6

Reaction Conditions
1.1 Reagents: Diisobutylaluminum hydride Solvents: Toluene ;  40 min, 0 °C; 1 h, 0 °C
2.1 Reagents: Oxygen Catalysts: Laccase Solvents: Ethanol ,  Water ;  pH 5, rt; 1 h, rt
2.2 Reagents: Hydrochloric acid Solvents: Water ;  acidified
Reference
An enantiocomplementary dirigent protein for the enantioselective laccase-catalyzed oxidative coupling of phenols
Pickel, Benjamin; et al, Angewandte Chemie, 2010, 49(1), 202-204

Production Method 7

Reaction Conditions
1.1 Reagents: Acetyl chloride Solvents: Ethanol ;  0 °C; 2 d, rt
2.1 Reagents: Diisobutylaluminum hydride Solvents: Toluene ;  40 min, 0 °C; 1 h, 0 °C
3.1 Reagents: Oxygen Catalysts: Laccase Solvents: Ethanol ,  Water ;  pH 5, rt; 1 h, rt
3.2 Reagents: Hydrochloric acid Solvents: Water ;  acidified
Reference
An enantiocomplementary dirigent protein for the enantioselective laccase-catalyzed oxidative coupling of phenols
Pickel, Benjamin; et al, Angewandte Chemie, 2010, 49(1), 202-204

Production Method 8

Reaction Conditions
1.1 Reagents: Glucose ,  Sucrose ,  Potassium chloride ,  Sulfuric acid magnesium salt (1:1) ,  Ferrous sulfate ,  Dipotassium phosphate Solvents: Dimethyl sulfoxide ,  Water ;  72 h, 25 °C
Reference
Enantioselective accumulation of (-)-pinoresinol through O-demethylation of (±)-eudesmin by Aspergillus niger
Kasahara, Hiroyuki; et al, Phytochemistry, 1997, 44(8), 1479-1482

Production Method 9

Reaction Conditions
1.1 Reagents: Oxygen ;  2 h, pH 4.5, 45 °C
Reference
Laccase catalyses phytophenol furanocyclic dimerization: Substrate specificity and diastereoselective process
Li, Xican ; et al, Journal of Molecular Structure, 2023, 1274,

Production Method 10

Reaction Conditions
1.1 Reagents: Hydrochloric acid Solvents: Diethyl ether ;  3 h, rt
2.1 Reagents: Glucose ,  Sucrose ,  Potassium chloride ,  Sulfuric acid magnesium salt (1:1) ,  Ferrous sulfate ,  Dipotassium phosphate Solvents: Dimethyl sulfoxide ,  Water ;  72 h, 25 °C
Reference
Enantioselective accumulation of (-)-pinoresinol through O-demethylation of (±)-eudesmin by Aspergillus niger
Kasahara, Hiroyuki; et al, Phytochemistry, 1997, 44(8), 1479-1482

(-)-pinoresinol Raw materials

(-)-pinoresinol Preparation Products

Additional information on (-)-pinoresinol

Recent Advances in the Study of (-)-Pinoresinol (CAS: 81446-29-9): A Comprehensive Research Brief

(-)-Pinoresinol, a lignan compound with the CAS number 81446-29-9, has garnered significant attention in the field of chemical biology and pharmaceutical research due to its diverse biological activities. Recent studies have explored its potential applications in anti-inflammatory, antioxidant, and anticancer therapies. This research brief synthesizes the latest findings on (-)-pinoresinol, focusing on its molecular mechanisms, therapeutic potential, and recent advancements in extraction and synthesis methodologies.

One of the most notable breakthroughs in (-)-pinoresinol research is its role in modulating inflammatory pathways. A 2023 study published in the *Journal of Natural Products* demonstrated that (-)-pinoresinol significantly inhibits the NF-κB signaling pathway, reducing the production of pro-inflammatory cytokines such as TNF-α and IL-6. This finding suggests its potential as a lead compound for developing novel anti-inflammatory drugs. Additionally, its antioxidant properties have been linked to the scavenging of reactive oxygen species (ROS), which are implicated in various chronic diseases.

In the realm of cancer research, (-)-pinoresinol has shown promise as an adjuvant therapy. A recent in vitro study revealed its ability to induce apoptosis in human breast cancer cells (MCF-7) by upregulating caspase-3 activity and downregulating Bcl-2 expression. These results, published in *Bioorganic & Medicinal Chemistry Letters*, highlight the compound's potential to enhance the efficacy of conventional chemotherapeutic agents while minimizing side effects.

Advances in the extraction and synthesis of (-)-pinoresinol have also been reported. A 2024 study in *Green Chemistry* introduced a sustainable enzymatic method for the stereoselective synthesis of (-)-pinoresinol, achieving a yield of 85% with minimal environmental impact. This method addresses the challenges associated with traditional chemical synthesis, such as low selectivity and high energy consumption, paving the way for scalable production.

Despite these promising developments, challenges remain in the clinical translation of (-)-pinoresinol. Pharmacokinetic studies indicate low oral bioavailability, necessitating the development of novel drug delivery systems. Recent efforts have explored nanoparticle-based formulations to enhance its solubility and stability, as reported in the *International Journal of Pharmaceutics*. These innovations could significantly improve the therapeutic potential of (-)-pinoresinol in clinical settings.

In conclusion, (-)-pinoresinol (CAS: 81446-29-9) represents a multifaceted compound with substantial therapeutic potential. Its anti-inflammatory, antioxidant, and anticancer properties, coupled with advancements in synthesis and delivery technologies, position it as a promising candidate for future drug development. Continued research is essential to overcome existing limitations and fully harness its benefits in biomedicine.

Recommended suppliers
Shanghai Joy Biotech Ltd
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Shanghai Joy Biotech Ltd
Hebei Liye chemical Co.,Ltd
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Hebei Liye chemical Co.,Ltd
Shanghai Hongxiang Biomedical Technology Co., Ltd.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Shanghai Hongxiang Biomedical Technology Co., Ltd.
Yunnanjiuzhen
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Yunnanjiuzhen
Shenzhen GeneSeqTools Bioscience & Technology Co. Ltd.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Reagent
Shenzhen GeneSeqTools Bioscience & Technology Co. Ltd.